More News
16 November 2023
Q32 Bio and Homology Medicines Announce Merger Agreement16 November 2023
Astellas to Acquire Propella Therapeutics8 November 2023
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer2 November 2023
Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap24 October 2023
Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics23 October 2023
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to form Sail Biomedicines19 October 2023
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences9 October 2023
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics5 October 2023
Kyowa Kirin to Acquire Orchard Therapeutics3 October 2023
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies30 September 2023
Novartis completes divestment of ‘front of eye’ ophthalmology assets28 September 2023
Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer’s disease and Huntington’s disease20 September 2023
Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines20 September 2023
Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery12 September 2023
Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer12 September 2023
Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform11 September 2023
Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium1 September 2023
Otsuka Pharmaceutical to Acquire Mindset PharmaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports